Renal safety and efficacy of angiotensin receptor‐neprilysin inhibitor: A meta‐analysis of randomized controlled trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renal safety and efficacy of angiotensin receptor‐neprilysin inhibitor: A meta‐analysis of randomized controlled trials
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-11
DOI
10.1111/jcpt.13243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study
- (2019) Duk-Hyun Kang et al. CIRCULATION
- Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
- (2019) Francesco Spannella et al. Internal and Emergency Medicine
- Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: A meta-analysis of randomized controlled trials
- (2019) Qiang Geng et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction
- (2019) Akshay S. Desai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
- (2019) Kevin S. Shah et al. CURRENT HYPERTENSION REPORTS
- US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States
- (2019) Rajiv Saran et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial
- (2018) Richard Haynes et al. CIRCULATION
- Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease
- (2018) Matthew James et al. CIRCULATION
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug
- (2017) Guillermo Gervasini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2017) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
- (2016) Surya P. Ayalasomayajula et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- What Physicians Need to Know About Renal Function in Outpatients with Heart Failure
- (2015) B�rd Waldum-Grevbo CARDIOLOGY
- Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
- (2015) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction
- (2015) Sadayoshi Ito et al. HYPERTENSION RESEARCH
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
- (2014) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Neprilysin inhibition in chronic kidney disease
- (2014) P. Judge et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
- (2013) K. Damman et al. EUROPEAN HEART JOURNAL
- Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency
- (2013) Kevin Damman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction
- (2011) Patrick Rossignol et al. CIRCULATION
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Changes in Kidney Function Following Heart Failure Treatment: Focus on Renin-Angiotensin System Blockade
- (2008) Ron Blankstein et al. Heart Failure Clinics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started